About Daarsh Innovations
Daarsh Innovations is a Healthcare company based in Raipur (India) founded in 2016 by Dinesh Aggarwal and Vijay Gupta. It operates as an antimicrobial products for dermal, intimate, and catheter infections are developed. Its chief executive is Dinesh Aggarwal. Its Indian entity Daarsh Innovations Private Limited reported revenue of ₹5 Lakh. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Diversified. Similar companies include Incyte, Biological E, Vir Biotechnology, LEO Pharma and Vaxcyte and 5 more; 8 of its 10 listed similar companies have raised funding.
Company details
Developer of antimicrobial products for treating dermal, women intimate area, and catheter infections. The company has developed a Clear topical spray used in the treatments of skin conditions such as Tinea Infections, Tinea Pedis (Athlete Foot), Tinea Cruris (Jock Itch), and others. It provides V Clear drug that helps in treating women intimate area infections caused by bacteria and yeast. The company offers SterCath that is a catheter lock solution that helps patients undergoing hemodialysis, chemotherapy, antibiotic therapy, among others. It reduces the infections within catheters and clot formation at the tip of the catheter.
- Headquarters Raipur, India
- Founders Dinesh Aggarwal, Vijay Gupta
- SectorsHealthcare
- Phone•••• ••••
- Website daarshinnovations.com
- Legal Name Daarsh Innovations Private Limited
- Date of Incorporation 10 May, 2016
- Jurisdiction Raipur, Chhattisgarh, India
- Annual Revenue₹5 Lakh
FY 2023 · +308% YoY
- Net Profit₹81,430
FY 2023 · 16% margin
- EBITDA₹88,688
FY 2023 · 18% margin
Associated legal entities of Daarsh Innovations
Daarsh Innovations operates through Daarsh Innovations Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Daarsh Innovations Private Limited CIN U52310CT2016PTC007261 | Active | 10 May 2016 | Raipur, Chhattisgarh | ₹0.1 Cr | – | 2 | View details |
Board of directors of Daarsh Innovations Private Limited (Daarsh Innovations)
Daarsh Innovations Private Limited is the primary company behind Daarsh Innovations. The board of Daarsh Innovations Private Limited currently have 2 directors; the longest-serving is Vijay Kumar Gupta, appointed in 2016. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vijay Kumar Gupta DIN 02130203 | Director | 10 May 2016 | 10 yrs 5 mo | Daarsh Innovations Private Limited |
| Sweta Gupta DIN 07895010 | Additional Director | 02 Apr 2024 | 2 yrs 6 mo | Daarsh Innovations Private Limited |
People of Daarsh Innovations
2 people are tracked at Daarsh Innovations (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for Daarsh Innovations
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Daarsh Innovations
Figures of Daarsh Innovations Private Limited, the primary company behind Daarsh Innovations, for FY 2023. Revenue was ₹5 Lakh (+308% year on year). Net profit was ₹81,430 (16% margin). EBITDA was ₹88,688 (18% margin). Revenue has grown at a compounded annual rate of +71% over three years and -24% over five years.
- ₹5 LakhRevenue · FY 2023 · +308% YoY
- ₹81,430Net profit · 16% margin
- ₹88,688EBITDA · 18% margin
- ₹1 LakhPaid-up capital
- +71%Revenue CAGR, 3 years
- -24%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Daarsh Innovations Private Limited are on its company page.
Detailed financial statements for Daarsh Innovations
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Daarsh Innovations
Daarsh Innovations has 10 listed similar companies in our database, 8 of them funded. They include Incyte, Biological E, Vir Biotechnology, LEO Pharma and Vaxcyte, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| incyte.com | 1991 | Wilmington, United States | – | 1,387 | Small molecules are developed for cancer and skin disease treatments. | |
| biologicale.com | 1953 | Hyderabad, India | – | 6,099 | Vaccines and therapeutics for multiple diseases are developed and marketed. | |
| vir.bio | 2017 | San Francisco, United States | $216M | 417 | Developer of therapeutics for the treatment of infectious diseases | |
| leo-pharma.com | 1908 | Copenhagen, Denmark | $560.38M | 142 | Developer of drugs for treating dermatology diseases | |
| vaxcyte.com | 2013 | Foster, United States | $347M | 254 | Vaccines for infectious diseases are developed using cell-free protein synthesis. | |
| cidara.com | 2013 | San Diego, United States | $78.35M | 90 | Novel anti-infectives for bacterial and fungal infections are developed. | |
| biontech.com | 2008 | Mainz, Germany | $805.99M | 4,530 | Immunotherapeutics for cancer and other diseases are developed. | |
| formation.bio | 2016 | New York, United States | $608M | – | AI-powered drug discovery platform for various diseases | |
| freeline.life | 2015 | Stevenage, United Kingdom | $273.69M | 152 | Gene therapy platform is developed for chronic disease treatments. | |
| arcutis.com | 2016 | Westlake Village, United States | $94.5M | 296 | Immunotherapeutic solutions for dermatological conditions are developed. |
Detailed similar companies of Daarsh Innovations
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Dermatology
10 companies that operate in the same segment as Daarsh Innovations (Dermatology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Developer of drugs for treating dermatology diseases | 1908 | Copenhagen, Denmark | USD 560.38 M | – | – | |
Skincare, beauty, and wellness services provided by VLCC across multiple countries. | 1989 | Delhi, Delhi, India | – | – | – | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Immunotherapeutic solutions for dermatological conditions are developed. | 2016 | Westlake Village, California, United States | USD 94.5 M | USD 376.07 M | 342 | |
Targeted small molecules are developed for oncology treatments. | 2010 | Singapore, Singapore | USD 100 M | – | – | |
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured. | 2014 | Pune, Maharashtra, India | USD 25.97 M | USD 18.15 M | 508 | |
Novel dermatologic therapies are developed for skin conditions. | 2012 | Malvern, Pennsylvania, United States | USD 82 M | USD 7.83 M | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Daarsh Innovations
Daarsh Innovations was founded in 2016.
Daarsh Innovations is headquartered in Raipur, India. It is registered at Raipur, Chhattisgarh, India.
Dinesh Aggarwal is the current CEO of Daarsh Innovations. They have also founded this company.
The primary company behind Daarsh Innovations, Daarsh Innovations Private Limited, reported revenue of ₹5 Lakh for FY 2023, up 308% year on year.
Developer of antimicrobial products for treating dermal, women intimate area, and catheter infections. The company has developed a Clear topical spray used in the treatments of skin conditions such as Tinea Infections, Tinea Pedis (Athlete Foot), Tinea Cruris (Jock Itch), and others. It provides V Clear drug that helps in treating women intimate area infections caused by bacteria and yeast. The company offers SterCath that is a catheter lock solution that helps patients undergoing hemodialysis, chemotherapy, antibiotic therapy, among others. It reduces the infections within catheters and clot formation at the tip of the catheter.
Daarsh Innovations's top competitors include Vaxcyte, BioNTech and LEO Pharma.
Daarsh Innovations operates through Daarsh Innovations Private Limited.
The legal entities of Daarsh Innovations currently have 2 directors, including Sweta Gupta, Vijay Kumar Gupta.